Skip to main content
Lipids in Health and Disease logoLink to Lipids in Health and Disease
. 2026 Jan 21;25:58. doi: 10.1186/s12944-026-02863-z

The association between maternal blood lipid trajectory and offspring preschool myopia in prospective and nested case‒control analyses

Jiao-Jiao Shi 1, Guang-Zhuang Jing 1, Xian-Gui He 2, Jing-Jing Wang 2, Yun-Hui Zhang 3, Hui-Jing Shi 1,✉
PMCID: PMC12905959  PMID: 41566299

Abstract

Background

The aim of this study was to investigate the association between maternal blood lipid trajectories during pregnancy and myopia in preschool offspring as well as the combined effects of maternal blood lipid trajectories and gestational diabetes mellitus (GDM) on myopia in offspring.

Methods

A prospective cohort design with a nested case‒control component was employed in this study. Visual outcomes in children aged 3–6 years, including both noncycloplegic refraction screening results and clinically validated diagnoses from medical records, were obtained. Maternal blood lipid trajectories were classified using group-based multi-trajectory modelling from repeat measurements of total cholesterol (TC) and triglycerides (TGs) during pregnancy in mothers with and without GDM as a complication. Modified Poisson regression models and generalized linear models were used to assess the associations between the maternal lipid trajectory and offspring myopia.

Results

Among the 4043 included mother‒child pairs, four distinct maternal lipid trajectories were identified: Group 1, “consistently normal TC and TG”; Group 2, “keeping normal TC but high TG”; Group 3, “moderately increasing TC and TG”; and Group 4, “highly increasing TC and TG”, accounting for 50.0% (n = 2078), 4.9% (n = 193), 41.0% (n = 1629), and 4.1% (n = 143) of the pairs, respectively. In the prospective cohort analysis, compared with membership in Group 1, membership in Groups 3 and 4 was associated with 21% (95% CI: 1.02–1.44) and 52% (95% CI: 1.06–2.20) increases in the risk of suspected myopia, respectively; when the mother had GDM as a complication, the relative risk was further elevated (RR = 1.52, 95% CI: 1.16–1.99 for “GDM + Group 3”). In the nested case‒control analysis, significant associations were also observed between the maternal lipid trajectory (Group 3: OR = 1.66, 95% CI: 1.02–2.72; Group 4: OR = 9.22, 95% CI: 1.05–80.66) and clinically diagnosed myopia; when the mother had GDM as a complication, these risks substantially increased (OR = 2.83, 95% CI: 1.06–7.59 for “GDM + Group 3”).

Conclusion

The results of this cohort study suggest that elevated gestational maternal blood lipid levels (including TC and TG levels) throughout pregnancy are associated with an increased risk of preschool myopia in the offspring. When these levels were considered in the context of GDM, the risks were further increased.

Graphical abstract

graphic file with name 12944_2026_2863_Figa_HTML.jpg

Supplementary Information

The online version contains supplementary material available at 10.1186/s12944-026-02863-z.

Keywords: Blood lipids, Pregnancy, Cohort study, Myopia, Refractive error, Child, Preschool

Introduction

Myopia constitutes more than 60% of refractive errors among children and adolescents [1, 2]. A shift toward earlier age of myopia onset has been widely documented across East Asia and Southeast Asia [3–5]. Unlike school-age myopia, preschool myopia often triggers strabismus and amblyopia, significantly increasing the lifelong risk of high myopia and macular degeneration [6, 7]. These findings underscore the urgent need to improve and popularize myopia prevention and control strategies [8]. Emerging evidence indicates that the presence of maternal cardiovascular metabolic diseases‌—‌such as diabetes and hypertensive disorders‌—‌may increase the risk of myopia in offspring [9, 10]. The identification of myopia risk factors related to‌ early metabolic ‌changes‌ during pregnancy may provide ‌key‌ insights into ‌the‌ epidemic trends of myopia [7]. In particular, maternal lipid levels represent crucial intrauterine environmental factors, as lipids can selectively cross the placental barrier to support the development of the foetal brain and visual system [11, 12]. The adverse health outcomes associated with gestational dyslipidaemia in offspring may persist into adulthood [13, 14]. However, few studies have investigated the associations between maternal lipid levels and myopia ‌risk‌.

Lipid levels are crucial for maintaining ocular function, protecting retinal health, and preserving the integrity of visual signal transduction [15]. Previous studies have demonstrated that hyperlipidaemia is associated with increased risks of meibomian gland dysfunction [16], retinopathy development [17], and choroidal thickening [18]. Hypercholesterolemia ‌may‌ disrupt the retinal vasculature through ‌multiple‌ mechanisms [19]. ‌Clinical evidence indicates that infants with hypertriglyceridemia have an increased risk of retinopathy of prematurity [20]. Recent studies have suggested that ‌gestational‌ lipid ‌profiles‌ may serve as ‌predictive biomarkers for‌ visual development ‌trajectories‌ up to ‌2 years of age [21]. However,‌ the associations between maternal ‌gestational‌ lipid levels and offspring myopia ‌remain‌ ‌elusive‌, ‌highlighting‌ the urgent need for‌ additional investigations. Moreover, given the ‌profound‌ fluctuations in blood lipids during pregnancy, ‌the objective and comprehensive characterization of‌ blood lipid ‌dynamics‌ in pregnant women is ‌a significant methodological challenge‌. ‌Group-based trajectory modelling (GBTM) effectively captures complex longitudinal patterns and characterizes their temporal profiles [22]. This approach, which serves as a robust analytical tool for‌ repeated-measures data, provides ‌clinically actionable‌ guidance for ‌optimizing‌ prenatal care practices. ‌Notably,‌ maternal dyslipidaemia during pregnancy ‌frequently co-occurs with‌ abnormalities in glucose metabolism, such as gestational diabetes mellitus (GDM) [23, 24]. Therefore, investigating the combined influence of maternal lipid levels and comorbid GDM on myopia development in offspring is a critical research priority.

In this study, it was hypothesized that prenatal‌ exposure to elevated maternal lipid levels is associated with an increased risk of myopia in preschool children and that the increase is ‌exacerbated‌ by ‌concurrent‌ GDM. The aims of this study, therefore, were to investigate the associations between ‌longitudinal‌ maternal lipid ‌trajectories‌ (‌specifically, total cholesterol (TC) and triglycerides (TG)) and myopia in offspring at 3–6 years of age ‌and to explore the contributions of comorbid GDM to these associations.

Methods

Study population

This study involved the use of data from the Shanghai Maternal‒Child Pairs Cohort (MCPC). Participant recruitment was conducted at two regional maternity hospitals in Shanghai, China, with 6,714 pregnant women enrolled between 2016 and 2018. The study was approved by the Fudan University Institutional Review Board (IRB number 201604-0587-EX), and all participants provided written informed consent. The methods used for the initial and follow-up MCPC studies have been described in detail previously [25]. Among the recruited mother‒child pairs,‌ 2,671 ‌were‌ excluded because of‌ multiple births, loss‌ to follow-up, ‌ major pre-existing‌ chronic conditions ‌including‌ diabetes ‌or‌ severe hyperlipidaemia, ‌or‌ missing lipid data. The current study comprises two sub-analyses, namely, a prospective cohort analysis and a nested case‒control analysis, ‌which‌ collectively ‌address‌ the research objectives.

(1) A total of 3,310 preschool children aged 3–6 years and their mothers were included in the prospective cohort analysis. ‌Visual‌ outcomes were ‌assessed using visual screening data obtained‌ from the Shanghai Child and Adolescent Large-scale Eye Study (SCALE) ‌through February 23, 2024 [26]. (2) While noncycloplegic refraction is suitable for large-scale population studies, it may overestimate the prevalence of myopia in preschool children [27]. Therefore, a nested case‒control study was conducted using cycloplegic refraction data for validation. The nested case‒control analysis was conducted through one-to-one propensity score matching involving age (within ≤1.0 years) and sex. ‌From clinical records ‌obtained through‌ the electronic medical registry,‌ 159 children who were diagnosed with myopia ‌by February 22, 2023, were selected as the case group. The control group consisted of 159 children ‌with‌ no documented‌ history of a myopia diagnosis ‌and‌ no suspected myopia ‌identified‌ during vision screenings ‌at‌ 3–6 years of age. The participant selection process is detailed in Fig. 1.

Fig. 1.

Fig. 1

Flow diagram of study participants. GBTM Group-based multi-trajectory modeling, TC total cholesterol, TG Triglycerides

Assessment of maternal lipid levels during pregnancy

The exposure in both analyses was ‌defined as‌ the maternal blood lipid trajectory (‌comprising‌ TC and TG) ‌throughout‌ pregnancy ‌combined with‌ GDM ‌status‌. During routine prenatal visits, blood was collected from participants after 8 to 10 h of fasting (‌water permitted‌). TC and TG levels were quantified ‌through‌ enzymatic assays ‌on‌ an Atellica Solution system (ADVIA 2120; Siemens Healthineers, Germany) ‌using‌ morning fasting samples. Maternal lipid levels during pregnancy were categorized into three stages according to the time of measurement: < 24 weeks, 24–32 weeks, and ≥ 33 weeks. All‌ examinations were ‌performed‌ by trained medical staff. Gestational hyperlipidaemia (GHL) was defined according to the trimester-specific reference intervals for lipid profiles established by Zheng et al. [28]. GDM ‌diagnoses‌ were ‌retrieved‌ from the‌ subjects’ electronic medical records. Lipid trajectories were analysed‌ using GBTM. GBTM is a generalization of univariate group-based trajectory modelling introduced by Nagin [22]. Trajectory models were constructed using the STATA Traj plugin with lipid indicators (TC and TG) measured during first, second🗍, and third pregnancy. The optimal latent class model was selected on the basis of a suite of fit indices, including the Bayesian information criterion (BIC), Akaike information criterion (AIC), entropy, and average posterior probability of assignment (APPA) [29]. Specifically, it met the following criteria: minimized BIC and AIC values; entropy > 0.7; APPA > 0.8; all class proportions > 2%; and sound theoretical interpretability.

Assessment of vision in children aged 3 to 6 years

The outcomes ‌included‌ suspected myopia ‌and‌ a diagnosis of myopia ‌in‌ children. Vision screening data ‌for‌ the prospective cohort analysis were sourced from the SCALE ‌study. The detailed methods have been previously reported [26]. Noncycloplegic refraction was ‌performed‌ to measure the spherical equivalent (SE) ‌with‌ an autorefractor (KR-8900; Topcon, Tokyo, Japan); the SE ‌was calculated as‌ sphere + cylinder/2. Owing to the strong inter-eye correlation in the SE (r = 0.74, P < 0.001), only the right-eye data were included in subsequent analyses; the left-eye data were used for sensitivity analysis. Suspected myopia was defined as an SE ≤ −0.75 D [30].

The myopia diagnosis data for the nested case‒control analysis were acquired from ‌the‌ electronic medical ‌records‌ of the subjects. ‌The diagnoses were made in accordance with the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10 ‌code‌ H52.1). ‌For‌ clinical ‌diagnosis‌, cycloplegic refraction was measured ‌after the administration of 0.5% tropicamide eye drops ‌five times at 5-minute intervals‌. Subjective refraction was measured ‌by‌ hospital-based optometrists ‌using ‌the standardized maximum plus ‌to‌ best visual acuity method 30 min post-instillation. A diagnosis of myopia was defined as an SE ≤ −0.50 D.

Covariates

Parental characteristics included maternal age, maternal education level (middle school ‌or below‌, high school, and college ‌or above‌), pre-pregnancy body mass index (BMI, calculated as weight in kilograms divided by height in metres squared; normal‌: 18.5–23.9, ‌underweight‌: < 18.5, and ‌overweight‌: ≥ 24.0), last menstrual period, father’s age, total annual family income (renminbi (RMB) < 100,000 [<$13,806], RMB 100,000–200,000 [$13,806–$27,613], and RMB > 200,000 [>$27,613]), and history of parental myopia (none or at least one). Child factors included gestational age at delivery (not preterm [≥ 37 weeks] and preterm [< 37 weeks]), birth weight (normal [2500–4000 g], low birth weight [< 2500 g], and macrosomia [> 4000 g]), sex (male or female), age, daily outdoor time (< 1.0, 1.0–1.9, and ≥ 2.0 h), near-work time (< 1.0, 1.0–1.9, and ≥ 2.0 h), screen time (< 1.0, 1.0–1.9, and ≥ 2.0 h), and sleeping time. The mother’s age, pre-pregnancy BMI, last menstrual period, and gestational age at delivery, and the child’s sex and age were extracted from medical records. Gestational age was calculated using the last menstrual period and delivery date. Maternal education, paternal age, family income, and parental myopia data were obtained via baseline questionnaires. Data on children’s myopia-related behaviours (outdoor time, near work, screen time, and sleep duration) were collected through follow-up questionnaires for ‌participants aged 3–6 years, with follow-up completed on March 6, 2024.

Statistical analysis

Statistical analysis was performed from May 12, 2024, to November 23, 2024. Continuous normally distributed variables are reported as the mean ± standard deviation (SD), whereas non-normally distributed data are reported as the median and interquartile range (IQR). Categorical variables are presented as counts (%). All‌ significance tests were 2-tailed, and P < 0.05 was considered to indicate statistical significance. All analyses were conducted using R ‌software‌ version 4.2.2 and Stata version 15.1.

Comparisons between maternal lipid trajectory groups and overall myopia prevalence were conducted using ‌both‌ chi-square tests and linear trend analyses. In the prospective cohort analysis, modified Poisson regression models [31] were used to estimate risk ratios (RRs) with 95% confidence intervals (CIs) to evaluate associations among maternal lipid trajectories, GDM ‌complications‌, and suspected myopia in offspring. ‌For the nested case‒control analysis, generalized linear models were employed to examine differences in myopia diagnosis on the basis of maternal lipid trajectories and GDM status. All the models were adjusted for offspring sex, age, gestational age, birth weight, outdoor activity time, near-work duration, screen exposure time, and sleep duration; maternal education and pre-pregnancy BMI; parental ages and myopia history; and family income. Left-eye data were also used to identify suspected myopia cases as part of a sensitivity analysis.

Results

A total of 4,043 ‌mother‒offspring pairs with complete‌ blood lipid data during pregnancy were ‌enrolled‌ in this study. Boys accounted for 50.51% (n = 1672) of the children participating in the prospective cohort analysis and 52.20% (n = 166) of the children participating in the nested case‒control analysis. The mean (SD) ages in the two analyses were 4.70 (0.40) years and 4.99 (0.59) years, respectively. During follow-up at 3–6 years of age, among all 4043 children, 491 (12.1%) were suspected to have myopia, including 82 with a diagnosis of myopia. The baseline characteristics of the parents and children are presented in Table 1. Table S1 in the Supplement shows the characteristics of the included and excluded parents and offspring; the included parents had a higher economic status, educational attainment and prevalence of myopia, and age was greater among both parents and children.

Table 1.

Characteristics of parents and offspring

Characteristic Prospective cohort analysis Nested case control analysis
(n = 3310) (n = 318)
Parents’ characteristics
Maternal age, y 29.25 ± 4.13 29.13 ± 3.89
Maternal lipid level < 24 GW
 TC, mmol/L 4.66(4.04, 5.17) 4.75(4.19, 5.17)
 TG, mmol/L 1.46(1.12, 1.94) 1.55(1.16, 1.95)
Maternal lipid level at 24–32 GW
 TC, mmol/L 6.16(5.48, 6.81) 6.15(5.47, 6.76)
 TG, mmol/L 2.24(1.8, 2.78) 2.15(1.77, 2.78)
Maternal lipid level in ≥ 33 GW
 TC, mmol/L 6.18(5.39, 7.09) 5.95(5.29, 6.72)
 TG, mmol/L 2.87(2.25, 3.65) 2.85(2.25, 3.52)
GDM 686(20.73) 72(22.64)
Prepregnancy BMI, kg/m²
 18.5–23.9 2225(67.22) 209(65.72)
 < 18.5 520(15.71) 38(11.95)
 ≥ 24.0 565(17.07) 71(22.33)
Maternal educational level
 Middle school and below 213(6.44) 39(12.26)
 High School 1556(47.01) 157(49.37)
 College and above 1541(46.56) 122(38.36)
Total family income per year, RMB
 <100,000 814(24.59) 106(33.33)
 100,000–200,000 1445(43.66) 146(45.91)
 >200,000 1051(31.75) 66(20.75)
Father’s age, y 30.31 ± 4.67 30.06 ± 4.55
Parental myopia
 None 576(17.40) 52(16.35)
 At least one 2734(82.60) 266(83.65)
Offspring characteristics
Sex
 Male 1672(50.51) 166(52.20)
 Female 1638(49.49) 152(47.80)
Age, y 4.75 ± 0.40 4.99 ± 0.59
Birth weight
 Normal 3039(91.81) 280(88.05)
 Low birth weight 104(3.14) 12(3.77)
 Macrosomia 167(5.05) 26(8.18)
Gestational age at delivery
 Not preterm 3168(95.71) 304(95.60)
 Preterm 142(4.29) 14(4.40)
Daily outdoor time, h/d
 < 1.0 1523(46.01) 148(46.54)
 1.0–1.9.0.9 1241(37.49) 120(37.74)
 ≥ 2.0 546(16.50) 50(15.72)
Daily near work time, h/d
 < 1.0 2063(62.33) 169(53.14)
 1.0–1.9.0.9 940(28.40) 108(33.96)
 ≥ 2.0 307(9.27) 41(12.89)
Daily screen time, h/d
 < 1.0 2016(60.91) 206(64.78)
 1.0–1.9.0.9 904(27.31) 74(23.27)
 ≥ 2.0 390(11.78) 38(11.95)
Daily sleeping time, h/d 9.7(9.34, 10.07) 9.77(9.36, 10.14)
Overall myopia 491(14.83) -

GW Gestational weeks, TC Total cholesterol, TG Triglycerides, GDM Gestational diabetes, IQR Interquartile range, RMB Renminbi. Parental and children’s age are expressed as mean ± standard deviation, while other continuous variables are presented as medians (IQR) and categorical variables as counts (%)

On the basis of the model-adequacy criteria, four distinct blood lipid trajectories were identified (descriptive classifications of lipid trajectories are shown in Fig. 2, and model fit statistics are shown in Table S2 in the Supplement): Group 1 (“consistently normal TC and TG”)—accounting for‌ 50.0% (n = 2,078) of the sample, ‌this group remained‌ far below the GHL criteria, ‌with‌ sustained low total cholesterol (mean ≈ 5.0 mmol/L) and triglyceride (mean ≈ 2.1 mmol/L) levels; Group 2 (“keeping normal TC but high TG”)—accounting for 4.9% (n = 193), ‌these participants presented triglyceride levels that exceeded the GHL criteria throughout pregnancy (mean ≈ 4.7 mmol/L) ‌while maintaining‌ normal total cholesterol levels (mean ≈ 5.5 mmol/L); Group 3 (“moderately increasing TC and TG”)—accounting for‌ 41.0% (n = 1,629), ‌this group showed‌ progressive increases in total cholesterol (range 5.3–7.1 mmol/L) and triglyceride (range 1.6–3.1 mmol/L) levels over time; and Group 4 (“highly increasing TC and TG”)—accounting for‌ 4.1% (n = 143), ‌these participants demonstrated‌ steep elevations in total cholesterol (range 7.2–8.8 mmol/L) and triglyceride (range 2.4–4.8 mmol/L) levels. Longitudinal analysis revealed that the total cholesterol level tended to increase from Group 1 to Group 4 throughout gestation (P < 0.05). The peak triglyceride levels in Group 3 progressively increased with increasing gestational age relative to those in the other three groups (P < 0.05; Figure S1 in the Supplement).

Fig. 2.

Fig. 2

Four latent classifications of maternal lipid trajectory through whole pregnancy. TC Total cholesterol, TG Triglycerides, GHL Gestational hyperlipidemia. The grey dotted line is the reference of GHL represents the recommended value for hyperlipidemia through three pregnant trimesters

In comparisons between lipid trajectory groups and myopia outcomes, offspring in both the “moderately increasing TC and TG” ‌group‌ and the “highly increasing TC and TG” ‌group‌ presented ‌significantly greater‌ prevalences of both suspected myopia and diagnosed myopia ‌than those in the reference “consistently normal TC and TG” group (all P values < 0.05). Significant linear trends were observed from Group 1 to Group 4, with all P values < 0.01 (Figure S2 in the Supplement).

In the prospective cohort analysis with adjustment for key confounders, compared with offspring in the “consistently normal TC and TG” reference group, offspring in the “moderately increasing TC and TG” group had a 20% increase in their risk of suspected myopia (RR = 1.20, 95% CI: 1.02–1.44, P = 0.031), whereas those in the “highly increasing TC and TG” group presented a 52% increase in risk (RR = 1.52, 95% CI: 1.06–2.20, P = 0.024). Compared with the offspring of GDM-free with consistently normal TC and TG levels (reference group), the offspring of other groups had the following fully adjusted RRs for suspected myopia: RR = 1.26, 95% CI: 0.95–1.67 for GDM and consistently normal TC and TG; RR = 0.69, 95% CI: 0.38–1.25 for no GDM and normal TC but high TG; RR = 1.00, 95% CI: 0.50–2.02 for GDM and normal TC but high TG; RR = 1.20, 95% CI: 0.98–1.47 for no GDM and moderately elevated TC and TG; RR = 1.52, 95% CI: 1.16–1.99 for GDM and moderately elevated TC and TG; and RR = 1.61, 95% CI: 1.11–2.33 for highly increasing TC and TG (independent of GDM status) (Table 2).

Table 2.

Associations between maternal lipid trajectory, GDM and offspring suspected myopia in prospective cohort analysis

Lipid trajectories and GDM status No. with outcome/total No. (%) RR (95% CI) P value
Lipid trajectories
 Consistently normal TC and TG 222/1649 (13.46) 1 [Reference] NA
 Keeping normal TC but high TG 17/162 (10.49) 0.75(0.47, 1.18) 0.215
 Moderately increasing TC and TG 218/1337 (16.31) 1.21(1.02, 1.44) 0.031
 Highly increasing TC and TG 26/122 (21.31) 1.52(1.06, 2.20) 0.024
Lipid trajectories combined with GDM status
 Consistently normal TC and TG & No GDM 168/1330 (12.63) 1 [Reference] NA
 Consistently normal TC and TG & GDM 54/319 (16.93) 1.26(0.95, 1.67) 0.111
 Keeping normal TC but high TG & No GDM 10/110 (9.09) 0.69(0.38, 1.25) 0.223
 Keeping normal TC but high TG & GDM 7/52 (13.46) 1.00(0.50, 2.02) 1
 Moderately increasing TC and TG & No GDM 161/1048 (15.36) 1.20(0.98, 1.47) 0.072
 Moderately increasing TC and TG & GDM 57/289 (19.72) 1.52(1.16, 1.99) 0.003
 Highly increasing TC and TG 26/122 (21.31) 1.61(1.11, 2.33) 0.013

TC Total cholesterol, TG Triglycerides, NA Not applicable. All models adjusted for children sex, children age, family income, parental education, parental age, parental myopia, prepregnancy BMI, gestational week, birth weight, outdoor time, near work time, screen time and sleeping time

In the nested case‒control analysis with identical covariate adjustments, the “moderately increasing TC and TG” group was associated with a 66% increase in the risk of diagnosed myopia (OR = 1.66, 95% CI: 1.02–2.72, P = 0.043), whereas the “highly increasing TC and TG” group presented an 8.22-fold increase in risk (OR = 9.22, 95% CI: 1.05–80.66, P = 0.045). With respect to offspring whose mothers did not have GDM and had consistently normal TC and TG levels, the fully adjusted ORs for diagnosed myopia were as follows: OR = 1.19, 95% CI: 0.58–2.44 for offspring whose mothers had GDM and consistently normal TC and TG levels; OR = 2.90, 95% CI: 0.68–12.41 for offspring whose mothers had no GDM and maintained normal TC but high TG levels; OR = 0.65, 95% CI: 0.11–3.76 for offspring whose mothers had GDM and maintained normal TC but high TG levels; OR = 1.54, 95% CI: 0.89–2.66 for offspring whose mothers had no GDM and moderately elevated TC and TG levels; OR = 2.83, 95% CI: 1.06–7.59 for offspring whose mothers had GDM and moderately increasing TC and TG levels; and OR = 9.71, 95% CI: 1.10–85.81 for offspring whose mothers had high TC and TG levels (Table 3).

Table 3.

Associations between maternal lipid trajectory, GDM and offspring diagnosed myopia in nested case-control analysis

Lipids trajectories and GDM status No. of myopia cases Total No. OR (95% CI) P value
Lipid trajectories
 Consistently normal TC and TG 82 186 1 [Reference] NA
 Keeping normal TC but high TG 8 15 1.50(0.51, 4.42) 0.461
 Moderately increasing TC and TG 62 109 1.66(1.02, 2.72) 0.043
 Highly increasing TC and TG 7 8 9.22(1.05, 80.66) 0.045
Lipid trajectories combined with GDM status
 Consistently normal TC and TG & No GDM 61 144 1 [Reference] NA
 Consistently normal TC and TG & GDM 21 42 1.19(0.58, 2.44) 0.637
 Keeping normal TC but high TG & No GDM 6 9 2.90(0.68, 12.41) 0.152
 Keeping normal TC but high TG & GDM 2 6 0.65(0.11, 3.76) 0.627
 Moderately increasing TC and TG & No GDM 47 87 1.54(0.89, 2.66) 0.123
 Moderately increasing TC and TG & GDM 15 22 2.83(1.06, 7.59) 0.038
 Highly increasing TC and TG 7 8 9.71(1.10, 85.81) 0.041

TC Total cholesterol, TG Triglycerides, GDM Gestational diabetes, NA Not applicable. All models adjusted for children sex, children age, family income, parental education, parental age, parental myopia, prepregnancy BMI, gestational week, birth weight, outdoor time, near work time, screen time and sleeping time. The numbers of the “highly increasing TC and TG” group was too limited and they were analyzed as one group without further subcategorization based on GDM

Sensitivity analysis using left-eye data to screen for suspected myopia confirmed the stable association with maternal lipid trajectory (Supplementary Table S3). Maternal GDM was significantly associated with elevated risks of both suspected and diagnosed myopia in offspring (Supplementary Table S4). The myopia distribution patterns of offspring under different concurrent maternal GDM and lipid trajectory conditions are detailed in Supplementary Table S5.

Discussion

In this cohort study, four distinct maternal lipid trajectories were identified: “consistently normal TC and TG” (50.0%), “keeping normal TC but high TG” (4.9%), “moderately increasing TC and TG” (41.0%), and “highly increasing TC and TG” (4.1%), wherein the TC and TG levels gradually increased from the “consistently normal TC and TG” group to the “highly increasing TC and TG” group. Children in the “moderately increasing TC and TG” and “highly increasing TC and TG” groups presented a significantly greater risk of myopia than did children in the “consistently normal TC and TG” group in both the prospective cohort analysis and the nested case‒control analysis. When GDM was present as a complication, the risk of myopia further increased in all lipid trajectory groups.

Among the four maternal lipid trajectories identified in this economically developed city in China, only half of mothers followed the trajectory in which both TC and TG levels remained below the recommended maximum throughout the pregnancy. Nearly 5% of pregnant women consistently presented high TG levels throughout their pregnancy, while their TC levels remained relatively low. More than 40% of the pregnant women tended to have increased levels of TC and TG. Another 4% of pregnant women maintained high levels of both TC and TG that were higher than the reference values. Despite significant lipid fluctuations during pregnancy, the current national guidelines lack established diagnostic criteria for gestational hyperlipidaemia [32–34]. Notably, the present study revealed elevated myopia risk in offspring even at subthreshold maternal lipid levels, a finding that suggests that standardized lipid monitoring throughout pregnancy is necessary.

There has been limited research investigating the relationship between gestational lipid levels in mothers and myopia in offspring; however, some studies have suggested a potential correlation between visual acuity and lipid levels within the same individual. A population-based study demonstrated statistically significant correlations between serum lipid indicators and the spherical equivalent [35]. The accumulation of lipids and oxidative stress in the macula represent key pathogenic mechanisms in age-related macular degeneration [36, 37]. Hypercholesterolemia has been shown to impair retinal function by diminishing retinal ganglion cell density and reducing the thickness of the photoreceptor layer and the inner nuclear layer in animal models [38]. In murine‌ models, isolated dyslipidaemia has been shown to cause a reduction in retinal function and severely reduce b/a ratios [39]. Elevated low-density lipoprotein cholesterol (LDL-C) is positively associated with vascular endothelial damage, and high high-density lipoprotein cholesterol (HDL-C) may increase the risk of glaucoma [40]. However, while this study provides crucial epidemiological data for establishing pregnancy-specific lipid reference ranges, its clinical applicability is still limited: the unavailability of HDL/LDL measurements constrains the scope of the analysis and may affect the generalizability of the results.

Several mechanisms underlying the association between maternal lipid levels and myopia in offspring have been proposed. First, foetal genetic studies have demonstrated inverse correlations between elevated maternal total cholesterol and low-density lipoprotein (LDL)/triglyceride levels in umbilical cord blood lipid profiles [41]. Given the strong dependence of the foetal visual system on maternally derived fatty acids [42, 43], this nutritional imbalance may coincide with the observed abnormalities in the arachidonic acid and glycerophospholipid pathways in myopic children [44, 45]. The protective effects of omega-3 polyunsaturated fatty acids (ω−3 PUFAs) on choroidal thickness have been consistently shown in both animal models and Mendelian randomization analyses [46, 47]. Second, maternal hyperlipidaemia upregulates the expression of inflammatory mediators (including cytosolic phospholipase A2 and ‌cyclooxygenase-2) in the uterus, an effect that can be ameliorated by ω−3 PUFA supplementation [48]. This proinflammatory milieu may predispose the developing retina to oxygen-induced vascular endothelial growth factor (VEGF) dysregulation [49, 50], given the biphasic changes in VEGF mRNA induced by hyperlipidaemia [51] and neurovascular developmental alterations, as VEGF critically regulates retinal vascular permeability [52]. Genetic evidence has confirmed that VEGF-A, cluster of differentiation 6, and monocyte chemoattractant protein-2 have causal relationships with myopia [53], with VEGF-A mediating myopia progression through villous vascular regulation [54]. This is corroborated by elevated placental VEGF-A in lipid-disordered pregnancies complicated with GDM [55, 56], a response that is mechanistically linked to retinal inflammation and vascular leakage [57]. Collectively, these intrauterine stressors may lead to photoreceptor degeneration and permanent retinal damage in offspring [58]. These are considered hallmark features of axial myopia, and their manifestations include a reduced density of photoreceptor and retinal pigment epithelial cells, as well as retinal thinning [59].

This study demonstrated that both GDM and maternal hyperlipidaemia had independent effects on myopia risk in offspring. Although some intergroup differences lacked statistical significance (likely due to the limited sample size), the co-occurrence of elevated lipid levels with GDM had greater risk effects. Mechanistically, GDM and dyslipidaemia may synergistically impair placental development through suppression of placental glycolysis, dysregulation of lipid processing [60], and acceleration of placental age [61]. Notably, maternal GDM independently predisposes offspring to hyperlipidaemia [62], and hyperlipidaemia under hyperglycaemic conditions exacerbates mitochondrial dysfunction, a known driver of retinopathy [63]. A cohort study by Ting et al. [64] revealed that the presence of dyslipidaemia increases early retinal microvascular injury risk by 882% in patients with diabetes. These findings align with existing reports that GDM–dyslipidaemia comorbidity increases perinatal risks [65, 66], suggesting the existence of shared pathogenic pathways.

Strengths and limitations

The primary strength of the present study is its prospective cohort design, which enabled the collection of accurate data on exposure, outcomes, and covariates. ‌The possible influence of various covariates has been adjusted in multivariable models. Multiple potential confounding variables related to myopia, including family history of myopia, birth outcomes, and behavioural factors, were considered. A comprehensive approach was employed to classify lipid levels during pregnancy, providing evidence for establishing reference values for ‌gestational ‌hyperlipidaemia.

Several limitations ‌should also be noted‌. First, other refractive errors were not included in the analysis because of the inability to differentiate between hyperopia, astigmatism, and other types of refractive errors in the medical diagnosis ‌records‌. Second, the number of children ‌exposed to maternal GDM in the highly increasing TC and TG group was relatively small, limiting the ability to directly compare GDM, maternal lipid trajectories, or their combinations and potentially weakening the statistical power of the study while increasing the ‌risk of‌ errors. Third, the primary outcome was noncycloplegic refraction rather than cycloplegic refraction, which may have led to an overestimation of the prevalence of myopia in young children. To address this limitation, a nested case‒control analysis based on clinically diagnosed myopia was integrated as an adjunct to the prospective cohort analysis. However, cycloplegic studies are still needed to validate the results and compensate for this limitation. Fourth, this study focused solely on maternal TC and TG levels during pregnancy; further research is necessary to explore the associations of HDL-C, LDL-C, and other lipid markers with offspring myopia. Fifth, residual confounding ‌factors‌, such as postnatal environmental exposure and ‌dietary‌ nutrition, might exist. Sixth, owing to the limited follow-up duration, the findings cannot be extrapolated past the preschool period and do not allow the prediction of myopia risk beyond this stage. Seventh, the participants included in this study had a higher socioeconomic status than the excluded candidates, which may limit the generalizability of the findings. For pregnant women with pre-existing severe hyperlipidaemia, further specialized cohort studies are warranted.

Conclusion

Elevated maternal lipid levels, including TC and TG levels, are associated with an increased risk of myopia in offspring; when GDM is present as a complication, this risk is further elevated. These findings provide novel insights into the long-term prognosis of gestational glycaemic and lipid management and the clinical care of early-onset myopia in children. It is therefore imperative to monitor maternal lipid levels during pregnancy, especially in cases where blood glucose and lipid levels are concurrently elevated. Targeting these metabolic factors as an intervention strategy for early-onset myopia may contribute to improved long-term ocular health outcomes in offspring. Early vision screening is recommended for children born to mothers with glucose and lipid metabolism disorders.

Supplementary Information

Supplementary Material 1 (229.5KB, docx)

Acknowledgements

We would like to thank all the members of Shanghai MCPC, all the teachers, students, and staff from local government, hospitals and community health who participated in the cohort baseline and follow-up the cohort.

Abbreviations

AIC

Akaike information criterion

APPA

Average posterior probability of assignment

BIC

Bayesian information criterion

BMI

Body mass index

CI

Confidence interval

D

Dioptre

GDM

Gestational diabetes mellitus

GHL

Gestational hyperlipidaemia

GW

Gestational week

GBTM

Group-based trajectory modelling

HDL-C

High-density lipoprotein cholesterol

ICD-10

The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision

IQR

Interquartile range

LDL-C

Low-density lipoprotein cholesterol

NA

Not applicable

OR

Odds ratio

ω-3 PUFAs

Omega-3 polyunsaturated fatty acids

RMB

Renminbi

RR

Risk ratio

SE

Spherical equivalent

SD

Standard deviation

SCALE

The Shanghai Child and Adolescent Large-scale Eye Study

MCPC

The Shanghai Maternal‒Child Pairs Cohort

TC

Total cholesterol

TG

Triglycerides

VEGF

Vascular endothelial growth factor

Authors’ contributions

JJS and HJS designed and conceptualized this study. JJS conducted and drafted the manuscript, HJS and GZJ critically revised and reviewed the manuscript. JJS, GZJ, JJW, XGH, YHZ and HJS collected data. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. HJS and JJS are the guarantors of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Funding

This study was supported by the National Natural Science Foundation of China (82473654) and the Key Discipline Program of Sixth Round of the Three-year Public Health Action Plan (Year 2023–2025) of Shanghai, China: GWVI-11.1-32.

Data availability

Data are available for sharing upon reasonable request to the corresponding author.

Declarations

Ethics approval and consent to participate

Ethical approval was granted by the Ethics Committee of the School of Public Health at Fudan University (IRB# 2016-04-0587-EX). Written informed consent was acquired from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Tang Y, Chen A, Zou M, Liu Z, Young CA, Zheng D, et al. Prevalence and time trends of refractive error in Chinese children: A systematic review and meta-analysis. J Glob Health. 2021;11:08006. 10.7189/jogh.11.08006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Xiang KD, Wang JJ, Pan CW, Chen J, Qi ZY, Zou HD, et al. Analysis of one-year refractive progression and influencing factors among children aged 4–14 years in Shanghai. Chin J Sch Health. 2022;43(09):1309–13. 10.16835/j.cnki.1000-9817.2022.09.008. [Google Scholar]
  • 3.Wang J, Han Y, Musch DC, Li Y, Wei N, Qi X, et al. Evaluation and Follow-up of myopia prevalence among School-Aged children subsequent to the COVID-19 home confinement in Feicheng, China. JAMA Ophthalmol. 2023;141(4):333–40. 10.1001/jamaophthalmol.2022.6506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang L, Xu W, Wang X, Guo Y, Zhou Z, He X. Hyperopic reserve among 6- to 8-year-old primary school pupils in jing’an District, Shanghai. Shanghai J Prev Med. 2025;37(05):458–60. 10.19428/j.cnki.sjpm.2025.24683. [Google Scholar]
  • 5.Wu F, Sun CH, Htoon HM, Bernard JY, Yap F, Tham YC, et al. The longitudinal associations of reading, writing and screen time with myopia at age 9 years among children from the GUSTO birth cohort. Acta Ophthalmol Published Online Oct. 2025;1. 10.1111/aos.70009. [DOI] [PMC free article] [PubMed]
  • 6.Hu Y, Ding X, Guo X, Chen Y, Zhang J, He M. Association of age at myopia onset with risk of high myopia in adulthood in a 12-Year Follow-up of a Chinese cohort. JAMA Ophthalmol. 2020;138(11):1129–34. 10.1001/jamaophthalmol.2020.3451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Berntsen DA, Walline JJ. Delaying the onset of nearsightedness. JAMA. 2023;329(6):465–6. 10.1001/jama.2022.24386. [DOI] [PubMed] [Google Scholar]
  • 8.Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: A review and Meta-Analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. 10.1167/iovs.61.4.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Du J, Li J, Liu X, Liu H, Obel C, Shen H, et al. Association of maternal diabetes during pregnancy with high refractive error in offspring: a nationwide population-based cohort study. Diabetologia. 2021;64(11):2466–77. 10.1007/s00125-021-05526-z. [DOI] [PubMed] [Google Scholar]
  • 10.Li M, Huang C, Yang W, Lee PMY, Liu Y, Lin R, et al. Evaluation of hypertensive disorder of pregnancy and high refractive error in offspring during childhood and adolescence. JAMA Netw Open. 2023;6(4):e238694. 10.1001/jamanetworkopen.2023.8694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509(7501):503–6. 10.1038/nature13241. [DOI] [PubMed] [Google Scholar]
  • 12.Wong BH, Chan JP, Cazenave-Gassiot A, Poh RW, Foo JC, Galam DL, et al. Mfsd2a is a transporter for the essential ω-3 fatty acid docosahexaenoic acid (DHA) in eye and is important for photoreceptor cell development. J Biol Chem. 2016;291(20):10501–14. 10.1074/jbc.M116.721340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mulder JWCM, Kusters DM, van Roeters JE, Hutten BA. Lipid metabolism during pregnancy: consequences for mother and child. Curr Opin Lipidol. 2024;35(3):133–40. 10.1097/MOL.0000000000000927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lin XH, Gao L, Tian S, Klausen C, Guo MX, Gao Q, et al. Maternal high-fat-diet exposure is associated with elevated blood pressure and sustained increased leptin levels through epigenetic memory in offspring. Sci Rep. 2021;11(1):316. 10.1038/s41598-020-79604-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lewandowski D, Sander CL, Tworak A, Gao F, Xu Q, Skowronska-Krawczyk D. Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life. Prog Retin Eye Res. 2022;89:101037. 10.1016/j.preteyeres.2021.101037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Bu J, Wu Y, Cai X, Jiang N, Jeyalatha MV, Yu J, et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019;17(4):777–86. 10.1016/j.jtos.2019.06.002. [DOI] [PubMed] [Google Scholar]
  • 17.Tan H, Fu X, Chen Y, Wang Y, Chen D. Hyperlipidemia and lipid-lowering therapy in diabetic retinopathy (DR): A bibliometric study and visualization analysis in 1993–2023. Heliyon. 2023;9(10):e21109. 10.1016/j.heliyon.2023.e21109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yeung SC, You Y, Howe KL, Yan P. Choroidal thickness in patients with cardiovascular disease: A review. Surv Ophthalmol. 2020;65(4):473–86. 10.1016/j.survophthal.2019.12.007. [DOI] [PubMed] [Google Scholar]
  • 19.Rao H, Jalali JA, Johnston TP, Koulen P. Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives. Front Endocrinol (Lausanne). 2021;12:620045. 10.3389/fendo.2021.620045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.El-Sayyad HIH, Elmansi AA, Bakr EHM. Hypercholesterolemia-induced ocular disorder: ameliorating role of phytotherapy. Nutrition. 2015;31(11–12):1307–16. 10.1016/j.nut.2015.05.013. [DOI] [PubMed] [Google Scholar]
  • 21.Villar J, Ochieng RB, Gunier RB, Papageorghiou AT, Rauch S, McGready R, et al. Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study. Lancet Diabetes Endocrinol. 2022;10(10):710–9. 10.1016/S2213-8587(22)00215-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Res. 2018;27(7):2015–23. 10.1177/0962280216673085. [DOI] [PubMed] [Google Scholar]
  • 23.Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015;122(5):643–51. 10.1111/1471-0528.13261. [DOI] [PubMed] [Google Scholar]
  • 24.Layton J, Powe C, Allard C, Battista MC, Doyon M, Bouchard L, et al. Maternal lipid profile differs by gestational diabetes physiologic subtype. Metabolism. 2019;91:39–42. 10.1016/j.metabol.2018.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gui Y, Zhao Y, Tao XG, Xu W, Yang Q, Wang Y, et al. Cohort profile: the Shanghai Maternal-Child pairs cohort (MCPC). Int J Epidemiol. 2024;53(1):dyad185. 10.1093/ije/dyad185. [DOI] [PubMed] [Google Scholar]
  • 26.He X, Zhao R, Sankaridurg P, Zhu J, Naduvilath T, Ma Y, et al. Design and methodology of the Shanghai child and adolescent large-scale eye study (SCALE). Clin Exp Ophthalmol. 2018;46(4):329–38. 10.1111/ceo.13065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sankaridurg P, He X, Naduvilath T, Lv M, Ho A, Smith E, et al. Comparison of noncycloplegic and cycloplegic autorefraction in categorizing refractive error data in children. Acta Ophthalmol. 2017;95(7):e633–40. 10.1111/aos.13569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zheng W, Zhang L, Tian Z, Zhang L, Liang X, Li G. Establishing reference ranges of serum lipid level during pregnancy and evaluating its association with perinatal outcomes: A cohort study. Int J Gynaecol Obstet. 2022;156(2):361–9. 10.1002/ijgo.13636. [DOI] [PubMed] [Google Scholar]
  • 29.Shi JJ, Zhu YH, Jing GZ, Guo MY, Ma FF, Shi HJ. Multiple trajectories of life style indicators and their links to myopia in the middle school students: A Five-Year cohort study. Sci Rep. 2025;15(1):32995. 10.1038/s41598-025-17953-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sankaridurg P, Berntsen DA, Bullimore MA, Cho P, Flitcroft I, Gawne TJ, et al. IMI 2023 digest. Invest Ophthalmol Vis Sci. 2023;64(6):7. 10.1167/iovs.64.6.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6. 10.1093/aje/kwh090. [DOI] [PubMed] [Google Scholar]
  • 32.Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023). Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51(3):221–55. 10.3760/cma.j.cn112148-20230119-00038. [DOI] [PubMed] [Google Scholar]
  • 33.Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. 10.1016/j.atherosclerosis.2019.08.014. [DOI] [PubMed] [Google Scholar]
  • 34.Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129–50. 10.1016/j.cjca.2021.03.016. [DOI] [PubMed] [Google Scholar]
  • 35.Yu Y, Chen H, Wang Z, Ye Y, Zhang Z, Bao Y, et al. Exploring the relationship between refractive errors and common chronic diseases via blood biochemistry tests: A large prospective cohort study. Invest Ophthalmol Vis Sci. 2024;65(13):26. 10.1167/iovs.65.13.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Handa JT, Cano M, Wang L, Datta S, Liu T. Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(4):430–40. 10.1016/j.bbalip.2016.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Qu Y, Liu Y, Fang J, Chen C, Cheng L, Xu X, et al. Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC–MS/MS lipidomics. Lipids Health Dis. 2025;24(1):302. 10.1186/s12944-025-02735-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shibata M, Sugiyama T, Hoshiga M, Hotchi J, Okuno T, Oku H, et al. Changes in optic nerve head blood flow, visual function, and retinal histology in hypercholesterolemic rabbits. Exp Eye Res. 2011;93(6):818–24. 10.1016/j.exer.2011.09.014. [DOI] [PubMed] [Google Scholar]
  • 39.Montgomery CL, Johnson HM, Johnston TP, Koulen P. Mechanisms underlying Early-Stage changes in visual performance and retina function after experimental induction of sustained dyslipidemia. Neurochem Res. 2018;43(8):1500–10. 10.1007/s11064-018-2563-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ma Y, Wu Y, Hu L, Chen W, Zhang X, Zheng D, et al. Associations between serum lipids and glaucoma: a cohort study of 400 229 UK biobank participants. Br J Ophthalmol. 2025;109(7):775–83. 10.1136/bjo-2024-326062. [DOI] [PubMed] [Google Scholar]
  • 41.Huang S, Liu S, Huang M, He JR, Wang C, Wang T, et al. The born in Guangzhou cohort study enables generational genetic discoveries. Nature. 2024;626(7999):565–73. 10.1038/s41586-023-06988-4. [DOI] [PubMed] [Google Scholar]
  • 42.Lutty GA, McLeod DS. Development of the hyaloid, choroidal and retinal vasculatures in the fetal human eye. Prog Retin Eye Res. 2018;62:58–76. 10.1016/j.preteyeres.2017.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Najm S, Löfqvist C, Hellgren G, Engström E, Lundgren P, Hård AL, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial. Clin Nutr ESPEN. 2017;20:17–23. 10.1016/j.clnesp.2017.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Du B, Jin N, Zhu XR, Lu DQ, Jin CC, Li Z, et al. A prospective study of serum metabolomic and lipidomic changes in myopic children and adolescents. Exp Eye Res. 2020;199. 10.1016/j.exer.2020.108182. [DOI] [PubMed]
  • 45.Lin X, Lei Y, Pan M, Hu C, Xie B, Wu W, et al. Augmentation of scleral Glycolysis promotes myopia through histone lactylation. Cell Metab. 2024;36(3):511–e5257. 10.1016/j.cmet.2023.12.023. [DOI] [PubMed] [Google Scholar]
  • 46.Xue CC, Li H, Dong XX, Yu M, Soh ZD, Chong CCY, et al. Omega-3 polyunsaturated fatty acids as a protective factor for myopia. Am J Ophthalmol. 2024;268:368–77. 10.1016/j.ajo.2024.08.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mori K, Kuroha S, Hou J, Jeong H, Ogawa M, Ikeda S, et al. Lipidomic analysis revealed n-3 polyunsaturated fatty acids suppressed choroidal thinning and myopia progression in mice. Faseb J. 2022;36(6):e22312. 10.1096/fj.202101947R. [DOI] [PubMed] [Google Scholar]
  • 48.Tr RB. Dietary n-3 but not n-6 fatty acids down-regulate maternal dyslipidemia induced inflammation: A three-generation study in rats. Prostaglandins Leukot Essent Fat Acids. 2018;135:83–91. 10.1016/j.plefa.2018.07.007. [DOI] [PubMed] [Google Scholar]
  • 49.Kim CY, Jung E, Kim EN, Kim CJ, Lee JY, Hwang JH, et al. Chronic placental inflammation as a risk factor of severe retinopathy of prematurity. J Pathol Transl Med. 2018;52(5):290–7. 10.4132/jptm.2018.07.09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Lee J, Dammann O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med. 2012;17(1):26–9. 10.1016/j.siny.2011.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zhou Y, Xu T, Wu Y, Wei H, Peng J. Oxidative stress and inflammation in sows with excess backfat: Up-Regulated cytokine expression and elevated oxidative stress biomarkers in placenta. Anim (Basel). 2019;9(10):796. 10.3390/ani9100796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gogat K, Le Gat L, Van Den Berghe L, Marchant D, Kobetz A, Gadin S, et al. VEGF and KDR gene expression during human embryonic and fetal eye development. Invest Ophthalmol Vis Sci. 2004;45(1):7–14. 10.1167/iovs.02-1096. [DOI] [PubMed] [Google Scholar]
  • 53.Kang YT, Zhuang ZH, He X, Huang Y, Wang NL, Huang T, et al. Mendelian randomization supports causal effects of inflammatory biomarkers on myopic refractive errors. Eur J Ophthalmol. 2025;35(2):400–8. 10.1177/11206721241266871. [DOI] [PubMed] [Google Scholar]
  • 54.Wan T, Shi W, Liang R, Li T, Li B, Zhou X. VEGFA May be a potential marker of myopic choroidal thickness and vascular density changes. Sci Rep. 2024;14(1):20514. 10.1038/s41598-024-70616-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Zhang X, Qiu B, Wang Q, Sivaprasad S, Wang Y, Zhao L, et al. Dysregulated serum lipid metabolism promotes the occurrence and development of diabetic retinopathy associated with upregulated Circulating levels of VEGF-A, VEGF-D, and PlGF. Front Med (Lausanne). 2021;8:779413. 10.3389/fmed.2021.779413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sirico A, Rossi ED, Degennaro VA, Arena V, Rizzi A, Tartaglione L, et al. Placental diabesity: placental VEGF and CD31 expression according to pregestational BMI and gestational weight gain in women with gestational diabetes. Arch Gynecol Obstet. 2023;307(6):1823–31. 10.1007/s00404-022-06673-3. [DOI] [PubMed] [Google Scholar]
  • 57.Wang J, Xu X, Elliott MH, Zhu M, Le YZ. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010;59(9):2297–305. 10.2337/db09-1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Bourque SL, Kuny S, Reyes LM, Davidge ST, Sauvé Y. Prenatal hypoxia is associated with long-term retinal dysfunction in rats. PLoS ONE. 2013;8(4):e61861. 10.1371/journal.pone.0061861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jonas JB, Jonas RA, Panda-Jonas S. Clinical and histological aspects of the anatomy of myopia, myopic macular degeneration and myopia-associated optic neuropathy. Prog Retin Eye Res. 2025;109:101402. 10.1016/j.preteyeres.2025.101402. [DOI] [PubMed] [Google Scholar]
  • 60.Valent AM, Choi H, Kolahi KS, Thornburg KL. Hyperglycemia and gestational diabetes suppress placental Glycolysis and mitochondrial function and alter lipid processing. FASEB J. 2021;35(3):e21423. 10.1096/fj.202000326RR. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Shrestha D, Workalemahu T, Tekola-Ayele F. Maternal dyslipidemia during early pregnancy and epigenetic ageing of the placenta. Epigenetics. 2019;14(10):1030–9. 10.1080/15592294.2019.1629234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Yang X, Leng J, Liu H, Wang L, Li W, Li W, et al. Maternal gestational diabetes and childhood hyperlipidemia. Diabet Med. 2021;38(11):e14606. 10.1111/dme.14606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kowluru RA, Mishra M, Kowluru A, Kumar B. Hyperlipidemia and the development of diabetic retinopathy: comparison between type 1 and type 2 animal models. Metabolism. 2016;65(10):1570–81. 10.1016/j.metabol.2016.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ting DS, Tan GS, Agrawal R, Yanagi Y, Sie NM, Wong CW, et al. Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathy. JAMA Ophthalmol. 2017;135(4):306–12. 10.1001/jamaophthalmol.2016.5877. [DOI] [PubMed] [Google Scholar]
  • 65.Shi P, Tang J, Yin X. Association between second- and third-trimester maternal lipid profiles and adverse perinatal outcomes among women with GDM and non-GDM: a retrospective cohort study. BMC Pregnancy Childbirth. 2023;23(1):318. 10.1186/s12884-023-05630-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Li Y, Wang X, Jiang F, Chen W, Li J, Chen X. Serum lipid levels in relation to clinical outcomes in pregnant women with gestational diabetes mellitus: an observational cohort study. Lipids Health Dis. 2021;20(1):125. 10.1186/s12944-021-0156. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (229.5KB, docx)

Data Availability Statement

Data are available for sharing upon reasonable request to the corresponding author.


Articles from Lipids in Health and Disease are provided here courtesy of BMC

RESOURCES